This site is intended for a global audience
Contact Us

Transfers of Value in Europe

Transfers of Value to Healthcare Professionals (HCPs), Healthcare Organisations (HCOs) and Patient Organizations in Europe

GW Pharmaceuticals is now Part of Jazz Pharmaceuticals

In line with local Transparency Reporting requirements, Jazz is disclosing its interactions with HealthCare Professionals, HealthCare Organisations and Patient Organizations in the following countries.

AustriaEFPIA Report 2017Methodological Note 2017
EFPIA Report 2018 Methodological Note 2018
EFPIA Report 2019 Methodological Note 2019
EFPIA Report 2020 Methodological Note 2020
EFPIA Report 2020 (English Version)
EFPIA Report 2021 Methodological Note 2021
EFPIA Report 2021 (English Version)
EFPIA Report 2021 (Legacy GW)
EFPIA Report 2022 Methodological Note 2022
EFPIA Report 2022 (English Version)
FinlandEFPIA Report 2019 Methodological Note 2019
EFPIA Report 2020 Methodological Note 2020
EFPIA Report 2020 (English Version)
EFPIA Report 2021 Methodological Note 2021
EFPIA Report 2021 (English Version)
EFPIA Report 2022 Methodological Note 2022
EFPIA Report 2022 (English Version)
GermanyEFPIA Report 2017Methodological Note 2017
EFPIA Report 2018Methodological Note 2018
EFPIA Report 2019

Methodological Note 2019
EFPIA Report 2020Methodological Note 2020
EFPIA Report 2020 (English Version)
EFPIA Report 2021Methodological Note 2021
EFPIA Report 2021 (English Version)
EFPIA Report 2021 (Legacy GW)
EFPIA Report 2022 Methodological Note 2022
EFPIA Report 2022 (English Version)
ItalyEFPIA Report 2017Methodological Note 2017
EFPIA Report 2018Methodological Note 2018
EFPIA Report 2019
Methodological Note 2019
EFPIA Report 2020
Methodological Note 2020
EFPIA Report 2021
Methodological Note 2021
EFPIA Report 2021 (Legacy GW)
EFPIA Report 2022
Methodological Note 2022
NorwayEFPIA Report 2019Methodological Note 2019
EFPIA Report 2020Methodological Note 2020
EFPIA Report 2020 (English Version)
EFPIA Report 2021 Methodological Note 2021
EFPIA Report 2021 (English Version)
EFPIA Report 2021 (Legacy GW)
EFPIA Report 2022Methodological Note 2022
EFPIA Report 2022 (English Version)
PolandEFPIA Report 2017
Methodological Note 2017
EFPIA Report 2018
Methodological Note 2018
EFPIA Report 2019
Methodological Note 2019
EFPIA Report 2020
Methodological Note 2020
EFPIA Report 2020 (English Version)
EFPIA Report 2021
Methodological Note 2021
EFPIA Report 2021 (English Version)
EFPIA Report 2021 (Legacy GW)
EFPIA Report 2022
Methodological Note 2022
EFPIA Report 2022 (English Version)
SpainEFPIA Report 2017
Methodological Note 2017
EFPIA Report 2018
Methodological Note 2018
EFPIA Report 2019
Methodological Note 2019
EFPIA Report 2020
Methodological Note 2020
EFPIA Report 2020 (English version)
EFPIA Report 2021
Methodological Note 2021
EFPIA Report 2021 (English Version)
EFPIA Report 2021 (Legacy GW)
EFPIA Report 2022Methodological Note 2022
EFPIA Report 2022 (English Version)
SwedenEFPIA Report 2019Methodological Note 2019
EFPIA Report 2020Methodological Note 2020
EFPIA Report 2020 (English Version)
EFPIA Report 2021Methodological Note 2021
EFPIA Report 2021 (English Version)
EFPIA Report 2021 (Legacy GW)
EFPIA Report 2022 Methodological Note 2022
EFPIA Report 2022 (English Version)
SwitzerlandEFPIA Report 2017
Methodological Note 2017
EFPIA Report 2018
Methodological Note 2018
EFPIA Report 2019
Methodological Note 2019
EFPIA Report 2020Methodological Note 2020
EFPIA Report 2021
Methodological Note 2021
Patient Organization Donations 2018
EFPIA Report 2022
Methodological Note 2022
IrelandPatient Organization Donations 2017
Patient Organization Donations 2018
Patient Organization Donations 2019
EFPIA Report 2021 (Legacy GW)
EuropeEFPIA Patient Organization Disclosure 2018Methodological Note 2018
EFPIA Patient Organization Disclosure 2019Methodological Note 2019
EFPIA Patient Organization Disclosure 2020Methodological Note 2020
EFPIA Patient Organization Disclosure 2021Methodological Note 2021
EFPIA Patient Organization Disclosure 2022
EFPIA Patient Organization Disclosure 2020 / 2019 (GW Pharmaceuticals)
EFPIA Patient Organization Disclosure 2021 (GW Pharmaceuticals)
Methodological Note 2021 (Legacy GW HCO/HCO Reports)